SMARCC1 Monoclonal Antibody
-
中文名稱:SMARCC1鼠單克隆抗體
-
貨號:CSB-MA209004
-
規(guī)格:¥2621
-
其他:
產(chǎn)品詳情
-
產(chǎn)品描述:CUSABIO貨號:CSB-MA209004 SMARCC1單克隆抗體是專為科研實驗設(shè)計的核心檢測工具,靶向染色質(zhì)重塑復(fù)合物BAF的核心亞基SMARCC1蛋白。該蛋白作為SWI/SNF復(fù)合物關(guān)鍵成員,通過調(diào)控核小體空間構(gòu)象參與細胞分化、DNA修復(fù)等重要生物學過程,其異常表達與腫瘤發(fā)生及神經(jīng)系統(tǒng)疾病密切相關(guān)。本產(chǎn)品采用高純度重組蛋白免疫制備,經(jīng)ELISA和Western Blot雙平臺驗證,可特異性識別人類來源的SMARCC1抗原表位,適用于染色質(zhì)動力學研究、癌癥分子機制探索以及基因表達調(diào)控網(wǎng)絡(luò)分析等前沿領(lǐng)域。抗體經(jīng)嚴格質(zhì)控確保批次穩(wěn)定性,為研究SWI/SNF復(fù)合物功能、建立疾病相關(guān)蛋白互作模型提供可靠檢測方案,特別推薦用于腫瘤微環(huán)境研究、表觀遺傳學實驗及基因編輯驗證等場景。該產(chǎn)品符合國際通用抗體標準,滿足分子生物學實驗對高靈敏度和特異性的雙重需求,助力科研人員精準解析SMARCC1在染色質(zhì)重塑中的分子調(diào)控機制。
-
別名:AI115498; BAF 155; BAF155; BRG 1 associated factor 155; BRG1 associated factor 155; BRG1-associated factor 155; Chromatin remodeling complex BAF155 subunit; CRACC 1; CRACC1; Mammalian chromatin remodeling complex BRG 1 associated factor 155;
-
宿主:Mouse
-
反應(yīng)種屬:Human
-
免疫原:Purified recombinant Human BAF155 protein fragments expressed in E.coli.
-
免疫原種屬:Homo sapiens (Human)
-
克隆類型:Monoclonal
-
抗體亞型:IgG1
-
純化方式:Affinity purified
-
克隆號:23E5
-
濃度:It differs from different batches. Please contact us to confirm it.
-
產(chǎn)品提供形式:Purified mouse monoclonal in PBS(pH 7.4) containing with 0.02% sodium azide and 50% glycerol.
-
應(yīng)用范圍:ELISA,WB
-
推薦稀釋比:
Application Recommended Dilution WB 1:500-1:5000 -
Protocols:
-
儲存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途:For Research Use Only. Not for use in diagnostic or therapeutic procedures.
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-